INSURANCE-PROVIDER PANELS
HB3796 amends the Illinois Network Adequacy and Transparency Act to strengthen continuity-of-care protections when a provider leaves a health plan network or when a new enrollee’s current provider is outside the plan’s network but within the service area. In those situations, the bill requires the network plan to allow the beneficiary to continue an ongoing course of treatment with the provider for a transitional period, generally up to 90 days. It also adds a specific 90-day transitional period for beneficiaries with a confirmed appointment that was scheduled before notice of disaffiliation or before enrollment, and it extends protection for beneficiaries in the third trimester of pregnancy through postpartum care directly related to delivery.
The bill also sets conditions for how transitional care is paid and administered. During the transition period, the provider must generally be reimbursed under the terminated contract’s terms for existing beneficiaries, or at rates established by the plan for new beneficiaries, and must comply with the plan’s quality assurance rules, referral procedures, and preauthorization requirements. The bill excludes coverage if the patient has already transitioned to another in-network provider, has exhausted plan benefits, or the care is not medically necessary. It also states that the section cannot be used to require coverage for benefits not otherwise covered or to reduce preexisting-condition limitations, and it requires provider compliance with the federal continuity-of-care requirement in 42 U.S.C. 300gg-138.
The bill’s impact is to amend 215 ILCS 124/20 and expand statutory continuity-of-care obligations for health insurance network plans and providers in Illinois. It creates more explicit rights for patients to keep seeing a departing or out-of-network provider for a limited time, especially for ongoing treatment, scheduled appointments, and late-stage pregnancy care. It also clarifies the reimbursement and administrative rules that apply during the transition period, which affects insurers, providers, and beneficiaries in group health and network plan arrangements.
Overall sentiment appears strongly favorable and noncontroversial. The bill passed the House 115-0 and later advanced in the Senate 57-0, indicating broad bipartisan support and no recorded opposition in the available voting history. No committee transcript is available, but the unanimous votes suggest the measure was viewed as a consumer-protection and patient-continuity bill rather than a contested policy change.
The main points of contention, based on the text itself, would likely concern the balance between patient access and insurer/network administration. The bill preserves plan limits by excluding non-medically necessary care and by allowing plans to enforce their policies, reimbursement terms, and preauthorization rules, while also creating new exceptions for confirmed appointments and pregnancy-related care. Any debate would likely center on the cost and operational burden for insurers versus the benefit of avoiding disruptions in treatment for patients.
HB3796 amends Section 20 of the Network Adequacy and Transparency Act (215 ILCS 124/20) to require network plans to provide transitional continuity of care in specified circumstances. It expands protections for beneficiaries whose provider leaves the network and for new enrollees whose current provider is outside the network but within the service area, while also setting reimbursement, quality assurance, and procedural requirements for providers during the transition period. The bill takes effect January 1, 2027.
The available voting history shows overwhelming support: 115-0 in the House on third reading and 57-0 in the Senate motion. With no recorded committee testimony, the public record available here suggests the bill was broadly viewed as a patient-protection measure with little or no visible opposition. The unanimity indicates a generally favorable sentiment across both chambers.
No explicit opposition appears in the available materials, but the text suggests the likely policy tension is between continuity of care for patients and the administrative and financial obligations placed on insurers and providers. The bill requires plans to continue coverage temporarily, reimburse providers under specified terms, and honor confirmed appointments and pregnancy-related care, while also preserving plan controls over medical necessity, benefit limits, referrals, and preauthorization. Those issues would be the most likely areas of concern for insurers and network administrators, though no recorded objections are provided here.